Application of response surface methodology and factorial designs to clinical trials for drug combination development

Area of Science:

• Pharmacology and Biostatistics
• Clinical Trial Design

Background:

• Hypertension treatment often involves drug combinations.
• Developing optimal fixed-dose combination therapies presents challenges in determining efficacy.
• Existing trial designs may not adequately assess synergistic effects.

Purpose of the Study:

• To discuss the application of response surface methodology (RSM) in analyzing factorial trials for combination hypertension treatments.
• To review analysis plans and efficacy results, focusing on quadratic RSM.
• To address the critical issue of establishing effective combination doses and its impact on drug design.

Main Methods:

• Utilized response surface methodology, specifically quadratic models, for analyzing factorial trial data.
• Applied methods to assess the efficacy of combination treatments compared to monotherapy.
• Explored direct approaches within RSM to identify optimal combination doses.

Main Results:

• Quadratic response surface methods were applied to analyze treatment efficacy.
• The study identified challenges in testing for effective dose combinations.
• Estimating the combination dose that maximizes the minimum gain over monotherapy emerged as a promising approach.

Conclusions:

• Response surface methodology provides a framework for analyzing complex combination treatments.
• Determining the optimal combination dose requires specific statistical approaches.
• Maximizing the minimum gain over monotherapy is a viable strategy for combination drug development.